Key facts
- SKN TO SKN’s last known valuation is $4.0M (Jul 2025).
- It has raised $970K; the latest was Angel (individual) ($760K) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for SKN TO SKN
- ·The full record, as it builds
Funding rounds
No funding rounds for SKN TO SKN are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SKN TO SKN
Manufacturer of skincare products intended to support women through TTC (trying to conceive), pregnancy, breastfeeding, and postpartum. The company offers dermatologist-formulated skincare products, serum, cleanser, and cream, tailored for all stages of motherhood, enabling women to safely care for their skin during sensitive life phases.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 3
- Website
- skntoskn.com/
- Ownership
- Privately Held (backing)
SKN TO SKN doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SKN TO SKN shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SKN TO SKN in its N-PORT filings yet. We sweep new filings monthly.